妊娠期高血压指南.docVIP

妊娠期高血压疾病执行摘要 Hypertension in Pregnancy: Executive Summary （ACOG 2013） The American College of Obstetricians and Gynecologists (the College) convened a task force of experts in the management of hypertension in pregnancy to review available data and publish evidence-based recommendations for clinical practice. The Task Force on Hypertension in Pregnancy comprised 17 clinician-scientists from the fields of obstetrics, maternal-fetal medicine, hypertension, internal medicine, nephrology, anesthesiology, physiology, and patient advocacy. This executive summary includes a synopsis of the content and task force recommendations of each chapter in the report and is intended to complement, not substitute, the report. 美国妇产科学会组织专家通过回顾现有的研究数据及基于证据的建议颁布了妊娠期高血压疾病的临床指南。妊高病专家组成员由的17位专家组成，他们来自临床专家，产科学、母胎医学、高血压疾病、内科学、肾脏学、麻醉学、生理学和患方维权者。这个执行摘要包括内容概要和每章节的专家组推荐。它不是替代而是补充说明该报告。 Hypertensive disorders of pregnancy remain a major health issue for women and their infants in the United States. Preeclampsia, either alone or superimposed on preexisting (chronic) hypertension, presents the major risk. Although appropriate prenatal care, with observation of women for signs of preeclampsia and then delivery to terminate the disorder, has reduced the number and extent of poor outcomes, serious maternal-fetal morbidity and mortality still occur. Some of these adverse outcomes are avoidable, whereas others can be ameliorated. Also, although some of the problems that face neonates are related directly to preeclampsia, a large proportion are secondary to prematurity that results from the appropriate induced delivery of the fetuses of women who are ill. Optimal management requires close observation for signs and premonitory findings and, after establishing the diagnosis, delivery at the optimal time for both maternal and fetal well-being. More recent clinical evidence to guide this timing is now available. Chronic hypertension is associated with fetal morbidity in the form of growth restriction and mat